Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 618-939-5 | CAS number: 933999-84-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 989
- Report date:
- 1989
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- 2-({[6-({1-chloro-3-[(oxiran-2-yl)methoxy]propan-2-yl}oxy)hexyl]oxy}methyl)oxirane; 2-[({6-[(oxiran-2-yl)methoxy]hexyl}oxy)methyl]oxirane; 3-chloro-2-({6-[(oxiran-2-yl)methoxy]hexyl}oxy)propan-1-ol; 6-[(oxiran-2-yl)methoxy]hexan-1-ol
- EC Number:
- 618-939-5
- Cas Number:
- 933999-84-9
- Molecular formula:
- C6H14O2 + C3H5ClO
- IUPAC Name:
- 2-({[6-({1-chloro-3-[(oxiran-2-yl)methoxy]propan-2-yl}oxy)hexyl]oxy}methyl)oxirane; 2-[({6-[(oxiran-2-yl)methoxy]hexyl}oxy)methyl]oxirane; 3-chloro-2-({6-[(oxiran-2-yl)methoxy]hexyl}oxy)propan-1-ol; 6-[(oxiran-2-yl)methoxy]hexan-1-ol
- Details on test material:
- As per IUCLID5 Sections 1.1. - 1.4.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- sprague-Dawley rats were obtained from Bantin & Kingman Ltd, Hull UK and were approximately ten to fourteen weeks of age. The males weighted 216 - 244 gm and the females weighted 211 - 232 gm upon arrival. The animals were grouped housed, 5 per polypropylene cage. Mains drinking water and feed (Rat and Mouse Expanded Diet No. 1, Special Diet Services Ltd, Essex, UK) were provided ad libitum. The animal room was maintained at 21 - 23 degrees with 54 - 67% relative humidity and a light/dark cycle of 12 hr. The rate of air exchange was approximately 15 per hour.
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- To an approximate 5 cm x 4 cm area on the back and flank of each animal the appropriate volume of neat test substance based upon specific gravity and animal body weight as applied using a graduated syringe. A piece of aluminium foil measuring approximately 7 cm x 4 cm was placed over the treated site. The site was occluded with a piece of self-adhesive bandage (HYPERTIE). The treated occluded area was secured BLENDERN wrap.
- Duration of exposure:
- 24 h
- Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- Animals were dermally exposed with occlusion to 1,6-Hexanediol Diglycidylether (HDDGE) for approximately 24 hr. Following the treatment period, the wrapping and dressing were removed and the treated area cleaned. The animals were observed for clinical signs and mortality 1 and 4 hr aftering dosing and at least once daily thereafter for 14 days. Body weights were taken the day of treatment (study day 0) and at study days 7 and 14. All animals were subjected to a gross necrospy and macroscopic examination.
- Statistics:
- No data
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- other: NOEL
- Effect level:
- 2 000 mg/kg bw
- Mortality:
- No mortalities.
- Clinical signs:
- other: No signs of systemic toxicity or skin irritation were noted during the study.
- Gross pathology:
- No abnormalities were noted at necropsy of animals sacrificed at the end of the study.
Applicant's summary and conclusion
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information via the dermal route of exposure. Criteria used for interpretation of results: expert judgment
- Conclusions:
- The no observed effect level (NOEL) of the test material, 1,6-Hexanediol Diglycidylether , in the Sprague-Dawley strain rat was found to be greater than 2000 mg/kg bodyweight. Therefore, Classification and Labeling for acute dermal exposure is not required.
- Executive summary:
1,6-Hexanediol Diglycidylether (HDDGE) was evaluated for acute dermal toxicity potential to rats in an O.E.C.D. 402 Testing Guideline study conducted with GLP compliance. No mortalities were observed in the study. The no observed effect level (NOEL) of the test material, 1,6-Hexanediol Diglycidylether , in the Sprague-Dawley strain rat was found to be greater than 2000 mg/kg bodyweight. Therefore, Classification and Labeling for acute dermal exposure is not required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
